You're viewing a public preview of Rare Pediatric Disease Priority Review Voucher (PPRV) Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Rare Pediatric Disease Priority Review Voucher (PPRV)

Active
United States
Sector: Life Science Entity: Private Founded: 2015
2015
Founded
Year established
3
Transactions
Sign up to view
$455M
Deal Value
Sign up to view
About Rare Pediatric Disease Priority Review Voucher (PPRV)
Within the AcquityData private market database, Rare Pediatric Disease Priority Review Voucher (PPRV) operates in the Life Science sector. The company is classified under the Life Science sector. Founded in 2015, it is headquartered in United States. Rare Pediatric Disease Priority Review Voucher (PPRV) is profiled within AcquityData.
Investors
Current Investors
United Therapeutics Corp. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
3 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 3 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Rare Pediatric Disease Priority Review Voucher (PPRV) M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Rare Pediatric Disease Priority Review Voucher (PPRV) do?
Within the AcquityData private market database, Rare Pediatric Disease Priority Review Voucher (PPRV) operates in the Life Science sector. The company is classified under the Life Science sector. Founded in 2015, it is headquartered in United States. Rare Pediatric Disease Priority Review Voucher (P
Where is Rare Pediatric Disease Priority Review Voucher (PPRV) headquartered?
Rare Pediatric Disease Priority Review Voucher (PPRV) is headquartered in United States.
When was Rare Pediatric Disease Priority Review Voucher (PPRV) founded?
Rare Pediatric Disease Priority Review Voucher (PPRV) was founded in 2015.
What sector is Rare Pediatric Disease Priority Review Voucher (PPRV) in?
Rare Pediatric Disease Priority Review Voucher (PPRV) operates in the Life Science sector.
Who are the investors in Rare Pediatric Disease Priority Review Voucher (PPRV)?
Current investors in Rare Pediatric Disease Priority Review Voucher (PPRV) include United Therapeutics Corp.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Rare Pediatric Disease Priority Review Voucher (PPRV) been involved in?
Rare Pediatric Disease Priority Review Voucher (PPRV) has 3 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Rare Pediatric Disease Priority Review Voucher (PPRV) profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Rare Pediatric Disease Priority Review Voucher (PPRV)'s complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial